Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-2
Closed 508
2022
Q1
$0 Sell
2
-47
-96% -$3.38K ﹤0.01% 1097
2021
Q4
$4K Sell
49
-2
-4% -$147 ﹤0.01% 670
2021
Q3
$4K Hold
51
﹤0.01% 711
2021
Q2
$3K Hold
51
﹤0.01% 814
2021
Q1
$4K Hold
51
﹤0.01% 640
2020
Q4
$4K Hold
51
﹤0.01% 593
2020
Q3
$3K Hold
51
﹤0.01% 619
2020
Q2
$3K Buy
51
+44
+629% +$2.16K ﹤0.01% 624
2020
Q1
$0 Sell
7
-61
-90% -$2.9K ﹤0.01% 1203
2019
Q4
$4K Buy
68
+38
+127% +$1.89K ﹤0.01% 560
2019
Q3
$2K Hold
30
﹤0.01% 735
2019
Q2
$1K Hold
30
﹤0.01% 944
2019
Q1
$1K Hold
30
﹤0.01% 566
2018
Q4
$1K Hold
30
﹤0.01% 561
2018
Q3
$1K Hold
30
﹤0.01% 575
2018
Q2
$1K Hold
30
﹤0.01% 565
2018
Q1
$1K Hold
30
﹤0.01% 574
2017
Q4
$1K Buy
+30
New +$1.2K ﹤0.01% 558

Other funds holding HOLX

Tarbox Family Office's HOLX Position: Q2 2022 in Review

Tarbox Family Office sold out of Hologic (HOLX) in Q2 2022, closing a stake of 2 shares.

Tarbox Family Office first reported a position in HOLX in Q4 2017 and held it in 18 quarters. The position peaked at $4K in Q4 2021. 695 funds tracked by Wall St. Rank hold HOLX as of Q2 2022.

  • Tarbox Family Office reported no remaining Hologic position as of Q2 2022 after selling out during the quarter.
  • Tarbox Family Office sold 2 Hologic shares in Q2 2022.
  • Tarbox Family Office first reported a position in Hologic in Q4 2017 and held it in 18 quarters.
  • Tarbox Family Office's Hologic position peaked at $4K in Q4 2021.
  • 695 funds tracked by Wall St. Rank held Hologic as of Q2 2022.

Based on Tarbox Family Office's 13F filing for Q2 2022, filed 19 Jul 2022.